Cut In Australia Drug Support Leads Seniors To Trim Use
This article was originally published in PharmAsia News
Executive Summary
A recent move by the Australian government to cut its share of the cost of drugs for retirees has led many to cut back on their medicines by an average of 11 percent. Some have stopped taking life-saving drugs, according to a study of the impact of the government move. The report says the biggest decline in drug use among the group was among those with asthma, blood-clot risks, osteoporosis and ulcers. A federal funding cut had a similar impact three years ago on the use of anti-cholesterol drugs. The price of some drugs for seniors increased by 90 percent after the federal-support reduction. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.